David V Elkins sold $2.7M of Bristol-Myers Squibb (BMY)

Executed Sep 2 2025, disclosed Sep 3 2025, 1 day later.

Value, as filed

$2.7M

56,000 sh × $47.33

Executed

Sep 2 2025

the trade date, as filed

Disclosed

Sep 3 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

David V Elkins EVP, Chief Financial Officer profile →

David V Elkins (EVP, Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Bristol-Myers Squibb Company (BMY). The largest single filing was $1.9M of BMY (30,000 sh across 2 lots, as filed), executed Apr 1.

The name

BMY

Bristol-Myers Squibb Company BMY · Healthcare · 25 filings in 24 months ticker →

Healthcare · Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldw…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by David V Elkins in BMY

BMYSALE Bristol-Myers Squibb Company $1.9M
30,000 sh across 2 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET